Search

everythinglearnresearchcommunity

for

Search:↓

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

New compounds were made that are promising for prostate cancer therapy.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Androgens improve memory in adolescent male rats by acting on brain receptors.

Analog 23 is a promising compound for prostate cancer treatment.

Androgens can affect glucocorticoid signaling in specific mouse brain areas.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

Dexamethasone increases androgen receptor activity in scalp cells, which might explain stress-related hair loss.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Sodium valproate helps skin healing by affecting GABA and histone deacetylase.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Activin A and follistatin control when ear hair cells form in mice.

Activin A promotes ear hair cell development, while follistatin delays it.

Activin A and follistatin control when hair cells develop in mouse ears.

Thiazole, a sulfur and nitrogen chemical, is useful in creating potential drugs for conditions like seizures, cancer, bacterial infections, tuberculosis, inflammation, malaria, viruses, Alzheimer's, diabetes, and A1-receptor issues.

TRPV channels are important in osteoarthritis and could be key to new treatments.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Weak endocrine disruptors in mixtures can have significant effects and should be considered in risk assessments.

Finasteride may improve prostate cancer treatment outcomes.